Alta Partners VIII, L.P.'s Net Worth
Estimate Recalculated Sep 15, 2025 08:39PM EST
Who is Alta Partners VIII, L.P.
Alta Partners VIII, L.P. has an estimated net worth of $39.5 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., ANESIVA, INC., ZS Pharma, Inc., Allakos Inc., SUTRO BIOPHARMA INC, Esperion Therapeutics, Inc., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., and ATS MEDICAL INC.
SEC CIK
Alta Partners VIII, L.P.'s CIK is 0001399763
Past Insider Trading and Trends
2014 was Alta Partners VIII, L.P.'s most active year for acquiring shares with 8 total transactions. Alta Partners VIII, L.P.'s most active month to acquire stocks was the month of June. 2015 was Alta Partners VIII, L.P.'s most active year for disposing of shares, totalling 19 transactions. Alta Partners VIII, L.P.'s most active month to dispose stocks was the month of May. 2014 saw Alta Partners VIII, L.P. paying a total of $7,194,708.00 for 6,018,675 shares, this is the most they've acquired in one year. In 2015 Alta Partners VIII, L.P. cashed out on 17,055,314 shares for a total of $35,700,680.80, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
